Akero Therapeutics (AKRO)
New Form 8-K - Akero Therapeutics, Inc. Filed: 2025-08-08 AccNo: 0001193125-25-176051 Size: 208 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
New Form 8-K - Akero Therapeutics, Inc. Filed: 2025-08-08 AccNo: 0001193125-25-176051 Size: 208 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
There are no comments here yet...